Sort
82,697 grants matching “vaccine development”
Therapeutic Use of an Enhanced Form of CD4-Ig
$934,552Michael R. Farzan · Scripps Florida · R37 · FY2019 · AI
Development of a Vaccine for the Prevention of Pulmonary Aspergillosis
$934,456Gary Fujii · Molecular Express, Inc. · R44 · FY2017 · AI
Clinical Development of Chimp Adenovirus Vectors
$934,348Hildegund C. J. Ertl · Wistar Institute · U19 · FY2007 · AI
Center of Excellence for Encephalitic Alphavirus Therapeutics
$934,276Colleen B Jonsson · University Of Tennessee Health Sci Ctr · U19 · FY2022 · AI
NOVEL HIV VACCINES
$934,250University Of Md Biotechnology Institute · P01 · FY2003 · AI
Strategies for Prevention of Autoimmunity
$934,000Stanford University · U19 · FY2005 · DK
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$933,971David S Stephens · Emory University · UM1 · FY2021 · AI
Development of VLP vaccine for RSV
$933,962Jorge C Blanco · Sigmovir Biosystems, Inc. · R42 · FY2016 · AI
Development of VLP vaccine for RSV
$933,962Jorge C Blanco · Sigmovir Biosystems, Inc. · R42 · FY2017 · AI
Vaccines and Therapeutics for Anthrax
$933,913Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Bridging gaps in healthcare services for new familes due to COVID-19
$933,793Emily Stinnett Miller · Women And Infants Hospital-Rhode Island · R01 · FY2023 · HD
MICROCHIP DRUG DELIVERY SYSTEM
$933,759Massachusetts Institute Of Technology · R24 · FY2003 · AI
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons
$933,677Laura J White · Univ Of North Carolina Chapel Hill · U01 · FY2010 · AI
Task A51: Small Animal Models for Biodefense Viruses
$933,508Connor Idso · Utah State University · N01 · FY2022 · AI
COVID-19 vaccine development research
$933,451Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Harvard Medical School Vaccine Clinical Trials Unit
$933,228Raphael Dolin · Beth Israel Deaconess Medical Center · U01 · FY2011 · AI
Core 1: Facility Management, Maintenance and Operations Core
$933,206Colin S. Duckett · Duke University · UC7 · FY2023 · AI
Mechanisms of mucosal protection induced by attenuated SIV
$933,169R. Paul Johnson · Harvard Medical School · P01 · FY2009 · AI
Influence of SIV replication on TB progression and immunity
$933,104Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Optimizing Antibody Vaccines Against HIV
$933,024William Schief · Massachusetts General Hospital · P01 · FY2016 · AI
Defining Drivers of HPV-associated Carcinogenesis
$933,000Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2024 · CA
Host Immunity Against Bacteria
$932,898Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$932,733Vanderbilt University · U01 · FY2001 · AI
Development of a Safer Smallpox Vaccine
$932,553Arizona State University-Tempe Campus · U01 · FY2004 · AI
Mali International Center for Excellence in Research: Vectors and Hosts of Parasitic Infectious Diseases
$932,468Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI